Pharmadrug

Sairiyo Therapeutics is a biotechnology company dedicated to repurposing and enhancing formulations of naturally derived compounds aimed at addressing serious, rare, and life-threatening diseases. The company is focused on obtaining regulatory approvals from the European Medicines Evaluation Agency and the U.S. Food and Drug Administration. One of its key developments is cepharanthine, which shows potential for treating various conditions, including cancer, neurological disorders, inflammatory diseases, and infections. Through its innovative approach, Sairiyo seeks to provide effective therapeutic options for patients facing significant health challenges.